beta hCG as a prognostic marker in adenocarcinoma of the prostate.

AIMS: To assess the importance of immunohistological detection of beta-human chorionic gonadotrophin (beta hCG) in localised prostatic adenocarcinoma with regard to prognosis and clinical applications. METHODS: Eighty consecutive cases of clinically localised adenocarcinoma of the prostate were stud...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Sheaff, M T, Martin, J E, Badenoch, D F, Baithun, S I
Format: Artigo
Idioma:Inglês
Publicat: 1996
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC500461/
https://ncbi.nlm.nih.gov/pubmed/8655711
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars